WEDELL-WEDELLSBORG JOHAN sold 14.7% of their position (89.17K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.37M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/3/2019ACC: 0001104659-19-048440
Director10% Owner
Since Sep 2018
-89.17K
Net shares
Net seller
$2.37M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
89.17K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−89.07K
Price / share
$26.58
Trade value
$2.37M
% of position
14.7%
8/29/2019
604.80K→515.74K
Common Stock
Indirect
Shares
−100.00
Price / share
$27.00
Trade value
$2.70K
% of position
0.0%
8/30/2019
515.74K→515.63K
Total
Net shares
−89.17K
Net value
-$2.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/29/2019 | S · Sale | −89.07K | $26.58 | $2.37M | 14.7% | 604.80K | 515.74K |
| Common Stock Indirect | 8/30/2019 | S · Sale | −100.00 | $27.00 | $2.70K | 0.0% | 515.74K | 515.63K |
| Total | −89.17K | -$2.37M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.01M
Total
5.01M indirect5.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.01M | Indirect |
| Total | 5.01M | 5.01M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported